Skip to main content
Top
Published in: Pediatric Cardiology 2/2006

01-04-2006

Neonate With Vein of Galen Malformation and Heart Failure: Serial Changes in Plasma B-Type Natriuretic Peptide Following Endovascular Embolization

Authors: L.H. Tan, B.A. Johnson, M.E. Mawad, A.C. Chang

Published in: Pediatric Cardiology | Issue 2/2006

Login to get access

Abstract

We report a neonate with vein of Galen malformation (VGM) who developed congestive heart failure (CHF) early after birth. Serial changes in plasma B-type natriuretic peptide (BNP) following an endovascular embolization procedure for VGM were mirrored in his clinical CHF status. The plasma BNP level markedly increased to 1800 pg/ml (normal, <100 pg/ml) in accordance with the severity of CHF. It rapidly decreased to 356 pg/ml during the first week after endovascular embolization for VGM. In the following 3 weeks there was an unexpected upward trend in plasma BNP despite echocardiography revealing normal biventricular function. After additional evaluation and treatment for CHF, BNP decreased again and the patient’s clinical status concurrently improved. The patient was discharged with a normal BNP level. Monitoring serial plasma BNP provides valuable information regarding the need for additional evaluation or treatment of newborns with CHF and may be used to document improvement.
Literature
1.
go back to reference Bettencourt P, Frioes F, Azevedo A, et al. (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure Int J Cardiol 93:45–48CrossRefPubMed Bettencourt P, Frioes F, Azevedo A, et al. (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure Int J Cardiol 93:45–48CrossRefPubMed
2.
go back to reference Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease Pediatr Cardiol 25:336–340CrossRefPubMed Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease Pediatr Cardiol 25:336–340CrossRefPubMed
3.
go back to reference Holmstrom H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants Acta Paediatr 90:184–191PubMed Holmstrom H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants Acta Paediatr 90:184–191PubMed
4.
go back to reference Johnston IH, Whittle IR, Besser M, Morgan MK (1987) Vein of Galen malformation: diagnosis and management Neurosurgery 20:747–758PubMed Johnston IH, Whittle IR, Besser M, Morgan MK (1987) Vein of Galen malformation: diagnosis and management Neurosurgery 20:747–758PubMed
5.
go back to reference Knecht M, Pagel I, Langenickel T, et al. (2002) Increased expression of renal neutral endopeptidase in severe heart failure Life Sci 71:2701–2712CrossRefPubMed Knecht M, Pagel I, Langenickel T, et al. (2002) Increased expression of renal neutral endopeptidase in severe heart failure Life Sci 71:2701–2712CrossRefPubMed
6.
go back to reference Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress Pediatr Cardiol 25:341–346CrossRefPubMed Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress Pediatr Cardiol 25:341–346CrossRefPubMed
7.
go back to reference Lubien E, DeMaria A, Krishnaswamy P, et al. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105:595–601CrossRefPubMed Lubien E, DeMaria A, Krishnaswamy P, et al. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105:595–601CrossRefPubMed
8.
go back to reference Maisel A, (2002) B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient Rev Cardiovasc Med 3(Suppl. 4): S10–S17PubMed Maisel A, (2002) B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient Rev Cardiovasc Med 3(Suppl. 4): S10–S17PubMed
9.
go back to reference Sodian R, Loebe M, Schmitt C, et al. (2001) Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems J Am Coll Cardiol 38:1942–1949CrossRefPubMed Sodian R, Loebe M, Schmitt C, et al. (2001) Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems J Am Coll Cardiol 38:1942–1949CrossRefPubMed
10.
go back to reference Tsutamoto T, Wada A, Maeda K, et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96:509–516PubMed Tsutamoto T, Wada A, Maeda K, et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96:509–516PubMed
11.
go back to reference Williams SG, Ng LL, O’Brien RJ, et al. (2004) Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure Am J cardiol 93:1560–1561PubMed Williams SG, Ng LL, O’Brien RJ, et al. (2004) Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure Am J cardiol 93:1560–1561PubMed
12.
go back to reference Yoshibayashi M, Kamiya T, Saito Y, et al. (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth Eur J Endocrinol 133:207–209PubMed Yoshibayashi M, Kamiya T, Saito Y, et al. (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth Eur J Endocrinol 133:207–209PubMed
Metadata
Title
Neonate With Vein of Galen Malformation and Heart Failure: Serial Changes in Plasma B-Type Natriuretic Peptide Following Endovascular Embolization
Authors
L.H. Tan
B.A. Johnson
M.E. Mawad
A.C. Chang
Publication date
01-04-2006
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 2/2006
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-005-1088-z

Other articles of this Issue 2/2006

Pediatric Cardiology 2/2006 Go to the issue